NASDAQ:FTH | Free Cash Flow | Faeth Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.73M$6,000.00-$10.74M
2025-12-31-$3.86M$0.00-$3.86M
2025-03-31-$7.09M$0.00-$7.09M
2024-12-31-$5.79M$0.00-$5.79M
2024-03-31-$7.62M$37,000.00-$7.65M
2023-12-31-$6.16M$0.00-$6.16M
2023-03-31-$11.74M$151,000.00-$11.89M
2022-12-31-$9.57M$0.00-$9.57M
2022-03-31-$10.75M$19,000.00-$10.77M
2021-12-31-$7.87M$535,000.00-$8.4M
2021-03-31-$10.77M$487,000.00-$11.25M
2020-12-31-$2.68M$316,000.00-$3M
2020-03-31-$6.46M$52,000.00-$6.51M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$20.45M$16,000.00-$20.47M
2024-12-31-$24.67M$146,000.00-$24.82M
2023-12-31-$32.02M$180,000.00-$32.2M
2022-12-31-$39.03M$321,000.00-$39.35M
2021-12-31-$30.26M$2.03M-$32.29M
2020-12-31-$17.71M$1.21M-$18.91M